Opportunities for Families

Visit MyFXResearch Portal to search for opportunities specific to you.

Seaside Therapeutics Harbor-C Trials

By |2012-11-06T11:08:49-05:00Nov 6, 2012|Opportunities for Families|

Seaside Therapeutics is studying the science of the brain and working to deliver treatments that improve the underlying causes of developmental disorders like Fragile X syndrome. Right now, Seaside is testing an investigational medicine called STX209 (arbaclofen) for individuals with Fragile X syndrome with social impairment. Thanks to the dedication and efforts of families, one of the clinical trials is almost complete.

Load More Posts